Buruli ulcer and current situation in Japan: A new emerging cutaneous Mycobacterium infection

Journal of Dermatology

Volumn 39, Issue 7, 2012, Pages 587-593

  Yotsu, Rie R ^a   Nakanaga, Kazue ^b   Hoshino, Yoshihiko ^b   Suzuki, Koichi ^b   Ishii, Norihisa ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Buruli ulcer; Mycobacterium ulcerans; Mycobacterium ulcerans ssp. shinshuense; Mycolactone; Non tuberculous mycobacteria

Indexed keywords

CLARITHROMYCIN; LEVOFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIMICROBIAL THERAPY; BACTERIAL SKIN DISEASE; BACTERIUM CULTURE; BURULI ULCER; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCUBATION TIME; JAPAN; MYCOBACTERIOSIS; MYCOBACTERIUM ULCERANS; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; SKIN TRANSPLANTATION; SMEAR; TREATMENT OUTCOME; VACCINATION;

BURULI ULCER; COMMUNICABLE DISEASES, EMERGING; HUMANS; JAPAN; MYCOBACTERIUM ULCERANS;

EID: 84862255902     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01543.x     Document Type: Review

References (36)

1. Global Buruli Ulcer Initiative (GBUI), World Health Organization. Buruli ulcer endemic countries [Internet]. 2011 [cited 2011 Nov 11]. Available from: http://www.who.int/buruli/country/en/index.html.
2. World Health Organization. First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases. Geneva, Switzerland: World Health Organization, 2010.
3. MacCallum P, Tolhurst JC, Buckle G, Sissons HA. A new mycobacterial infection inman. J Pathol Bacteriol 1948; 60: 92-122.
4. Clancey JK, Dodge OG, Lunn HF, Oduori ML. Mycobacterial skin ulcers in Uganda. Lancet 1961; 2: 951-954.
5. Merritt RW, Walker ED, Small PL et al. Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 2010; 4: e911. doi: 10.1371/journal.pntd.0000911
6. Portaels F, Chemlal K, Elsen P et al. Mycobacterium ulcerans in wild animals. Rev Sci Tech 2001; 20: 252-264.
7. Marsollier L, Sévérin T, Aubry J et al. Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol 2004; 70: 6296-6298.
8. Marsollier L, Robert R, Aubry J et al. Aquatic insects as a vector for Mycobacteriumulcerans. Appl Environ Microbiol 2002; 68: 4623-4628.
9. Eddyani M, Ofori-Adjei D, Teugels G et al. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol 2004; 70: 5679-5681.
10. Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne P, Meyers WN. Insects in the transmission of Mycobacterium ulcerans infection. Lancet 1999; 353: 986.
11. Portaels F, Meyers WM, Ablordey A et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2008; 2: e178.
12. Kotlowski R, Martin A, Ablordey A, Chemlal K, Fonteyne PA, Portaels F. One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish. J Med Microbiol 2004; 53: 927-933.
13. Trott KA, Stacy BA, Lifland BD et al. Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis). Comp Med 2004; 54: 309-317.
14. Sakaguchi K, Iima H, Hirayama K et al. Mycobacterium ulcerans Infection in an Indian Flap-shelled Turtle (Lissemys punctata punctata). J Vet Med Sci 2011; 73: 1217-1220.
15. Lavender CJ, Fyfe JA, Azuolas J et al. Risk of Buruli ulcer and detection of Mycobacteirum ulcerans in Mosquitos in Southeastern Australia. PLoS Negl Trop Dis 2011; 9: e1305.
16. Mikoshiba H, Shindo Y, Matsumoto H, Mochizuki M, Tsukamura M. A case of typical mycobacteriosis due to Mycobacterium ulcerans-like organism. Jpn J Dermatol 1982; 92: 557-565.
17. Tsukamura M, Mikoshiba H. A new mycobacterium which caused skin infection. Microbiol Immunol 1982; 26 (10): 951-955.
18. Tsukamura M, Kaneda K, Imaeda T, Mikoshiba H. A taxonomic study on a mycobacterium which caused skin ulcer in a Japanese girl and resembled Mycobacterium ulcerans. Jpn J Tubercul Chest Dis 1989; 64: 691-697.
19. Quek TY, Athan E, Henry MJ et al. Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 2007; 13 (11): 1661-1666.
20. Debacker M, Aguiar J, Steunou C et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004; 9 (12): 1297-1304.
21. Portaels F, Johnson P, Meyers WM. Buruli Ulcer: Diagnosis of Mycobacterium Ulcerans Disease (WHO/CDS/CPE/GBUI/2001.4). Geneva, Switzerland: World Health Organization, 2001.
22. Silva MT, Portaels F, Pedrosa J. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 2009; 9: 699-710.
23. En J, Goto M, Nakanaga K et al. Mycolactone is responsible for the painlessness of Mycobacaterium ulcerans infection (Buruli ulcer) in a murine study. Infect Immun 2008; 76: 2002-2007.
24. Nakanaga K, Ishii N, Suzuki K et al. "Mycobacterium ulcerans subsp. shinshuense" isolated from a skin ulcer lesion: identification based on 16S rRNA gene sequencing. J Clin Microbiol 2007; 45 (11): 3840-3843.
25. World Health Organization. Provisional Guidance on the Role of Specific Antibiotics in the Management of Mycobacterium ulcerans Disease (Buruli ulcer) (WHO/CDS/CPE/GBUI/2004). Geneva, Switzerland: World Health Organization, 2004.
26. Nienhuis WA, Stienstra Y, Thompson WA et al. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomized controlled trial. Lancet 2010; 37: 664-672.
27. Nakanaga K, Hoshino Y, Yotsu RR et al. Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J Clin Microbiol 2011; 49 (11): 3829-3836.
28. O'Brien DP, Robson ME, Callan PP, McDonald AH. "Paradoxical" immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure. Med J Aust 2009; 191: 564-566.
29. World Health Organization. Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 2008; 83: 145-156.
30. The Uganda Buruli study group. BCG vaccination against Mycobacterium ulcerans infection (Buruli ulcer): first results of a trial in Uganda. Lancet 1969; 293: 111-115.
31. Smith PG, Revill WD, Lukwago E, Rykushin YP. The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemicarea of Uganda. Trans R Soc Trop Med Hyg 1977; 70: 449-457.
32. Portaels F, Aguiar J, Debacker M et al. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 2002; 9: 1389-1391
33. Portaels F, Aguiar J, Debacker M et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004; 72: 62-65.
34. Nackers F, Dramaix M, Johnson RC et al. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg 2006; 75: 768-774.
35. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 1999; 354: 1013-1018.
36. Faber WR, Arias-Bouda LM, Zeegelaar JE et al. First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 2000; 94: 277-279.